ABSTRACT
Necrotizing enterocolitis (NEC) is a clinical syndrome of ischemic necrosis of the bowel of multiple etiological factors that include the presence of intestinal ischemia, abnormal bacterial flora, and intestinal mucosal immaturity. Numerous reports have implied that the fecal microflora may contribute to the pathogenesis of NEC. A broad range of organisms generally found in the distal gastrointestinal tract have been recovered from the peritoneal cavity and blood of infants with NEC. The predominant organisms include Enterobacteriaceae (i.e., Escherichia coli, Klebsiella pneumoniae), Clostridium spp., enteric pathogens (salmonellae, Coxsackie B2 virus, coronavirus, rotavirus), and potential pathogens (Bacteroides fragilis). The goals of the initial management is preventing ongoing damage, restoring hemostasis, and minimizing complications. Medical management includes withholding oral feeding, placement of nasogastric tube, abdominal decompression, paracentesis, vigorous intravenous hydration containing electrolytes and calories, support of the circulation, administration of antibiotics, and surveillance for deterioration or complications that require surgical intervention. Indications for surgery include clinical deterioration, perforation, peritonitis, obstruction, and abdominal mass. Prevention remains crucial to decrease the incidence of NEC. Preventive methods include cautious feeding regimens, the use of maternal breast milk, and the use of probiotics.
KEYWORDS
Necrotizing enterocolitis -
Clostridium spp. - sepsis - probiotics
REFERENCES
-
1
Neu J.
Neonatal necrotizing enterocolitis: an update.
Acta Paediatr Suppl.
2005;
94
100-105
-
2
Kafetzis D A, Skevaki C, Costalos C.
Neonatal necrotizing enterocolitis: an overview.
Curr Opin Infect Dis.
2003;
16
349-355
-
3
Stoll B J.
Epidemiology of necrotizing enterocolitis.
Clin Perinatol.
1994;
21
205-218
-
4
Llanos A R, Moss M E, Pinzon M C, Dye T, Sinkin R A, Kendig J W.
Epidemiology of neonatal necrotising enterocolitis: a population-based study.
Paediatr Perinat Epidemiol.
2002;
16
342-349
-
5
Panigrahi P.
Necrotizing enterocolitis: a practical guide to its prevention and management.
Paediatr Drugs.
2006;
8
151-165
-
6
Nowicki P T.
Ischemia and necrotizing enterocolitis: where, when, and how.
Semin Pediatr Surg.
2005;
14
152-158
-
7
Horton K K.
Pathophysiology and current management of necrotizing enterocolitis.
Neonatal Netw.
2005;
24
37-46
-
8
Updegrove K.
Necrotizing enterocolitis: the evidence for use of human milk in prevention and treatment.
J Hum Lact.
2004;
20
335-339
-
9
Bin-Nun A, Bromiker R, Wilschanski M.
Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates.
J Pediatr.
2005;
147
192-196
-
10
Lin H C, Su B H, Lin T W.
Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants.
Pediatrics.
2005;
115
1-4
-
11
Martinez-Tallo E, Claure N, Bancalari E.
Necrotizing enterocolitis in full-term or near-term infants: risk factors.
Biol Neonate.
1997;
71
292-298
-
12
Hsueh W, Caplan M S, Qu X W, Tan X D, De Plaen I G, Gonzalez-Crussi F.
Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts.
Pediatr Dev Pathol.
2003;
6
6-23
-
13
Krediet T G, van Lelyveld N, Vijlbrief D C et al..
Microbiological factors associated with neonatal necrotizing enterocolitis: protective effect of early antibiotic treatment.
Acta Paediatr.
2003;
92
1180-1182
-
14
Chan K L, Ng S P, Chan K W, Wo Y H, Tam P K.
Pathogenesis of neonatal necrotizing enterocolitis: a study of the role of intraluminal pressure, age and bacterial concentration.
Pediatr Surg Int.
2003;
19
573-577
-
15
Alfa M J, Robson D, Davi M, Bernard K, Van Caeseele P, Harding G K.
An outbreak of necrotizing enterocolitis associated with a novel Clostridium species in a neonatal intensive care unit.
Clin Infect Dis.
2002;
35
S101-S105
-
16
Warren S, Schreiber J R, Epstein M F.
Necrotizing enterocolitis and hemolysis associated with Clostridium perfringens
.
Am J Dis Child.
1984;
138
686-688
-
17
Kosloske A M, Ball Jr W S, Umland E, Skipper B.
Clostridial necrotizing enterocolitis.
J Pediatr Surg.
1985;
20
155-159
-
18
Novak R W, Klein R L, Novak P E.
Necrotizing enterocolitis, hemolysis, and Clostridium perfringens
.
Am J Dis Child.
1985;
139
114-115
-
19
Novak R W.
Bacterial-induced RBC alterations complicating necrotizing enterocolitis.
Am J Dis Child.
1984;
138
183-185
-
20
Kosloske A M, Ulrich J A, Hoffman H.
Fulminant necrotising enterocolitis associated with Clostridia
.
Lancet.
1978;
2(8098)
1014-1016
-
21
Howard F M, Flynn D M, Bradley J M, Noone P, Szawatkowski M.
Outbreak of necrotising enterocolitis caused by Clostridium butyricum
.
Lancet.
1977;
2
1099-1102
-
22
Sturm R, Staneck J L, Stauffer L R, Neblett III W W.
Neonatal necrotizing enterocolitis associated with penicillin-resistant, toxigenic Clostridium butyricum
.
Pediatrics.
1980;
66
928-931
-
23
Pedersen P V, Hansen F H, Halveg A B, Christiansen E D.
Necrotizing enterocolitis of the newborn-is it gas-gangrene of the bowel?.
Lancet.
1976;
2
715-716
-
24
Rousset S, Moscovici O, Lebon P et al..
Intestinal lesions containing coronavirus-like particles in neonatal necrotizing enterocolitis: an ultrastructure analysis.
Pediatrics.
1984;
73
218-224
-
25
Rotbart H A, Levin M J, Yolken R H, Manchester D K, Jantzen J.
An outbreak of rotavirus-associated neonatal necrotizing enterocolitis.
J Pediatr.
1983;
103
454-459
-
26
Noel G J, Laufer D A, Edelson P J.
Anaerobic bacteremia in a neonatal intensive care unit: an eighteen-year experience.
Pediatr Infect Dis J.
1988;
7
858-862
-
27
Brook I, Avery G, Glasgow A.
Clostridium difficile in pediatric infection.
J Infect.
1982;
4
253-257
-
28
Kosloske A M, Ulrich J A.
A bacteriologic basis for the clinical presentations of necrotizing enterocolitis.
J Pediatr Surg.
1980;
15
558-564
-
29
Kliegman R M, Fanaroff A A, Izant R, Speck W T.
Clostridia as pathogens in neonatal necrotizing enterocolitis.
J Pediatr.
1979;
95
287-289
-
30
Bartlett J G, Moon N, Chang T W, Taylor N, Onderdonk A B.
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.
Gastroenterology.
1978;
75
778-782
-
31
Chang T W, Areson P.
Neonatal necrotizing enterocolitis: absence of enteric bacterial toxins.
N Engl J Med.
1978;
299
424
-
32
Cashore W J, Peter G, Lauermann M, Stonestreet B S, Oh W.
Clostridia colonization and clostridial toxin in neonatal necrotizing enterocolitis.
J Pediatr.
1981;
98
308-311
-
33
Fumarola D.
Endotoxemia and neonatal necrotizing enterocolitis.
Am J Clin Pathol.
1985;
84
409
-
34
Edwards C A, Parrett A M.
Intestinal flora during the first months of life: new perspectives.
Br J Nutr.
2002;
88(Suppl 1)
S11-S18
-
35
Rotimi V O, Duerden B I.
The development of the bacterial flora in normal neonates.
J Med Microbiol.
1981;
14
51-62
-
36
Long S S, Swenson R M.
Development of anaerobic fecal flora in healthy newborn infants.
J Pediatr.
1977;
91
298-301
-
37
Kindley A D, Rboerts P J, Tulloch W H.
Neonatal necrotising enterocolitis.
Lancet.
1977;
1
649
-
38
Brook I, Barrett C T, Brinkman III C R, Martin W J, Finegold S M.
Aerobic and anaerobic flora of maternal cervix and newborn's conjunctiva and gastric fluid: a prospective study.
Pediatrics.
1979;
63
451-455
-
39
Waligora-Dupriet A J, Dugay A, Auzeil N, Huerre M, Butel M J.
Evidence for clostridial implication in necrotizing enterocolitis through bacterial fermentation in a gnotobiotic quail model.
Pediatr Res.
2005;
58
629-635
-
40 Finegold S M.
Anaerobic infections in human disease
. New York; 1977 Academic Press
-
41
Murrell T G.
Pigbel in Papua New Guinea: an ancient disease rediscovered.
Int J Epidemiol.
1976;
1983(12)
211-214
-
42
Lawrence G, Shann F, Freestone D S, Walker P D.
Prevention of necrotizing enteritis in Papua New Guinea by active immunization.
Lancet.
1979;
1
227-230
-
43
Kliegman R M, Fanaroff A A.
Necrotizing enterocolitis.
N Engl J Med.
1984;
310
1093-1103
-
44
Bell M J, Ternberg J L, Feigin R D et al..
Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging.
Ann Surg.
1978;
187
1-7
-
45
Faingold R, Daneman A, Tomlinson G et al..
Necrotizing enterocolitis: assessment of bowel viability with color Doppler US.
Radiology.
2005;
235
587-594
-
46
Henry M C, Moss R L.
Current issues in the management of necrotizing enterocolitis.
Semin Perinatol.
2004;
28
221-233
-
47
Bell M J, Kosloske A M, Benton C, Martin L W.
Neonatal necrotizing enterocolitis: prevention of perforation.
J Pediatr Surg.
1973;
8
601-605
-
48
Bell M J, Shackelford P G, Feigin R D, Ternberg J L, Brotherton T.
Alterations in gastrointestinal microflora during antimicrobial therapy for necrotizing enterocolitis.
Pediatrics.
1979;
63
425-428
-
49
Panigrahi P.
Necrotizing enterocolitis: a practical guide to its prevention and management.
Paediatr Drugs.
2006;
8
151-165
-
50
Faix R G, Polley T Z, Grasela T H.
A randomized, controlled trial of parenteral clindamycin in neonatal necrotizing enterocolitis.
J Pediatr.
1988;
112
271-277
-
51
Pierro A.
The surgical management of necrotising enterocolitis.
Early Hum Dev.
2005;
81
79-85
-
52
Moss R L, Dimmitt R A, Barnhart D C et al..
Laparotomy versus peritoneal drainage for necrotizing enterocolitis and perforation.
N Engl J Med.
2006;
354
2225-2234
-
53
Horwitz J R, Lally K P, Cheu H W, Vazquez W D, Grosfeld J L, Ziegler M M.
Complications after surgical intervention for necrotizing enterocolitis: a multicenter review.
J Pediatr Surg.
1995;
30
994-998
-
54
Reber K M, Nankervis C A.
Necrotizing enterocolitis: preventative strategies.
Clin Perinatol.
2004;
31
157-167
-
55
Bury R G, Tudehope D.
Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants.
Cochrane Database Syst Rev.
2001;
1
CD000405
-
56
Adler S P, Chandrika T, Berman W F.
Clostridium difficile associated with pseudomembranous colitis: occurrence in a 12-week-old infant without prior antibiotic therapy.
Am J Dis Child.
1981;
135
820-822
-
57
Nanthakumar N N, Young C, Ko J S et al..
Glucocorticoid responsiveness in developing human intestine: possible role in prevention of necrotizing enterocolitis.
Am J Physiol Gastrointest Liver Physiol.
2005;
288
G85-G92
-
58
Lee J S, Polin R A.
Treatment and prevention of necrotizing enterocolitis.
Semin Neonatol.
2003;
8
449-459
-
59
Foster J, Cole M.
Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth-weight neonates.
Cochrane Database Syst Rev.
2004;
1
CD001816
-
60
Caplan M S, Miller-Catchpole R, Kaup S et al..
Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model.
Gastroenterology.
1999;
117
577-583
-
61
Butel M J, Waligora-Dupriet A J, Szylit O.
Oligofructose and experimental model of neonatal necrotising enterocolitis.
Br J Nutr.
2002;
87
S213-S219
-
62
Hoyos A B.
Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit.
Int J Infect Dis.
1999;
3
197-202
-
63
Fuller R.
Probiotics in man and animals.
J Appl Bacteriol.
1989;
66
365-378
-
64
Neu J, Caicedo R.
Probiotics: protecting the intestinal ecosystem?.
J Pediatr.
2005;
147
143-146
-
65
Land M H, Rouster-Stevens K, Woods C R, Cannon M L, Cnota J, Shetty A K.
Lactobacillus sepsis associated with probiotic therapy.
Pediatrics.
2005;
115
178-181
Itzhak BrookM.D.
4431 Albemarle Street NW
Washington, DC 20016
